Details

IRB Study Number 4639

Status Recruiting

Location Cleveland Clinic Main Campus

Institute Taussig Cancer Institute

Description

Description

  1. Primary

    • To understand the genetic and molecular alterations that are involved in the pathogenesis, diagnosis, prognosis and response to therapy in renal cell carcinoma (RCC).

Inclusion Criteria

Inclusion Criteria

none

Exclusion Criteria

Exclusion Criteria

none